Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SXTP

SXTP News

Newswire

06:01

Ascendiant Capital Maintains Buy, Lowers PT to $2.8 from $3

08:05

60 Degrees Pharma's B-FREE Study for Chronic Babesiosis Begins Patient Enrollment.

08:03

HC Wainwright assumes Buy rating, raises PT to $6 on 60 Degrees.

07:17

60 Degrees Pharmaceuticals Submits Breakthrough Therapy Request to FDA

07:16

60 Degrees Pharmaceuticals Announces Positive Babesiosis Treatment Results in First Patient Study

View More

About SXTP

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More